Ralf Bartenschlager
German virologist and university teacher
Ralf Bartenschlager's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Ralf Bartenschlager Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ralf F. W. Bartenschlager is a German virologist who has been researching hepatitis C since 1989. He is a professor in the Department of Infectious Diseases at the Heidelberg University. Early life Bartenschlager grew up in Mannheim. After high school, he worked as a policemen for four years before starting his undergraduate in biology in 1981 at Heidelberg University. He conduced his thesis work with Heinz Schaller at the ZMBH in Heidelberg on the structure and functional role of the P-protein in Hepatitis B viruses. After graduating in 1990, he continued working as a postdoc at Heidelberg University until joining Hoffmann-La Roche in 1991, where he began working on Hepatitis C.
Ralf Bartenschlager's Published Works
Published Works
- Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. (1999) (2915)
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (2882)
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus (2005) (2398)
- The lipid droplet is an important organelle for hepatitis C virus production (2007) (1211)
- Replication of hepatitis C virus. (2000) (1174)
- Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites (2009) (923)
- Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. (2006) (784)
- Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons (2003) (696)
- Structures and distributions of SARS-CoV-2 spike proteins on intact virions (2020) (695)
- Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations (2001) (609)
- Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity (1997) (583)
- Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation (2001) (505)
- Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions (1993) (488)
- Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly (2008) (482)
- Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. (2011) (467)
- Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses (2006) (467)
- Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication (2012) (453)
- Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture (2003) (452)
- Assembly of infectious hepatitis C virus particles. (2011) (444)
- Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture (2002) (405)
- A short cis‐acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. (1990) (404)
- The Non-structural Protein 4A of Dengue Virus Is an Integral Membrane Protein Inducing Membrane Alterations in a 2K-regulated Manner* (2007) (404)
- Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs (2001) (393)
- SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography (2020) (386)
- Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions (2007) (380)
- Kissing-Loop Interaction in the 3′ End of the Hepatitis C Virus Genome Essential for RNA Replication (2005) (378)
- Host-directed therapies for bacterial and viral infections (2017) (373)
- Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication (2001) (368)
- Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome* (2010) (355)
- Kinetic and structural analyses of hepatitis C virus polyprotein processing (1994) (353)
- Novel insights into hepatitis C virus replication and persistence. (2004) (351)
- The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection (2013) (347)
- Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. (1992) (345)
- Genetic Analysis of Sequences in the 3′ Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication (2002) (326)
- Quantitative Analysis of the Hepatitis C Virus Replication Complex (2005) (306)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A* (2004) (305)
- Replication of the hepatitis C virus. (2000) (304)
- The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation (1990) (304)
- Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs (2002) (298)
- Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees (2002) (281)
- Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (2007) (280)
- Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics (2009) (275)
- The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro (2006) (274)
- Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion (2005) (272)
- Mutational Analysis of Hepatitis C Virus Nonstructural Protein 5A: Potential Role of Differential Phosphorylation in RNA Replication and Identification of a Genetically Flexible Domain (2005) (265)
- The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly* (2007) (264)
- Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation (1995) (263)
- Subcellular Localization and Membrane Topology of the Dengue Virus Type 2 Non-structural Protein 4B* (2006) (245)
- The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells (2006) (244)
- Strategies to inhibit entry of HBV and HDV into hepatocytes. (2014) (238)
- Architecture and biogenesis of plus-strand RNA virus replication factories. (2013) (233)
- Membranous Replication Factories Induced by Plus-Strand RNA Viruses (2014) (233)
- High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI* (2006) (233)
- Ultrastructural Characterization of Zika Virus Replication Factories (2017) (233)
- Viral immune modulators perturb the human molecular network by common and unique strategies (2012) (231)
- Rewiring cellular networks by members of the Flaviviridae family (2018) (230)
- Hepatitis C Virus RNA Replication and Assembly: Living on the Fat of the Land (2014) (226)
- Morphological and Biochemical Characterization of the Membranous Hepatitis C Virus Replication Compartment (2013) (224)
- Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes (2007) (216)
- From Structure to Function: New Insights into Hepatitis C Virus RNA Replication* (2006) (208)
- Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway (2001) (206)
- Novel cell culture systems for the hepatitis C virus. (2001) (203)
- Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly (2010) (202)
- The amino‐terminal domain of the hepadnaviral P‐gene encodes the terminal protein (genome‐linked protein) believed to prime reverse transcription. (1988) (201)
- Evidence for Novel Hepaciviruses in Rodents (2013) (188)
- DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A (2010) (187)
- miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. (2012) (186)
- Modulation of Hepatitis C Virus NS5A Hyperphosphorylation by Nonstructural Proteins NS3, NS4A, and NS4B (1999) (185)
- Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication (2004) (181)
- Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells (2020) (179)
- Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly* (2008) (179)
- Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses (2016) (178)
- Alternative Approaches for Efficient Inhibition of Hepatitis C Virus RNA Replication by Small Interfering RNAs (2004) (177)
- A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C. (2003) (176)
- Targeting of Hepatitis C Virus Core Protein to Mitochondria through a Novel C-Terminal Localization Motif (2004) (173)
- Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 (2006) (171)
- Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. (2002) (170)
- Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription (1994) (169)
- Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. (2010) (165)
- Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. (2012) (164)
- Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant (2007) (163)
- Hepatitis c virus and host cell lipids: An intimate connection (2011) (163)
- Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference (2009) (158)
- Divergent Roles of Autophagy in Virus Infection (2013) (158)
- Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B* (2009) (157)
- A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly (2011) (155)
- The Hepatitis C Virus RNA 3′-Untranslated Region Strongly Enhances Translation Directed by the Internal Ribosome Entry Site (2006) (154)
- Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins (2015) (153)
- Deregulation of miR‐92a expression is implicated in hepatocellular carcinoma development (2010) (153)
- Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. (1998) (152)
- Hepatitis C virus replicons: potential role for drug development (2002) (150)
- euHCVdb: the European hepatitis C virus database (2006) (149)
- Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. (2005) (148)
- Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication. (2014) (147)
- Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations (2009) (146)
- Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles (2008) (140)
- Flaviviridae Replication Organelles: Oh, What a Tangled Web We Weave. (2015) (140)
- Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. (2012) (139)
- Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus (2007) (139)
- Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins (2009) (139)
- The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy (1999) (139)
- Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies (2020) (138)
- NS4B Self-Interaction through Conserved C-Terminal Elements Is Required for the Establishment of Functional Hepatitis C Virus Replication Complexes (2011) (136)
- Endoplasmic Reticulum: The Favorite Intracellular Niche for Viral Replication and Assembly (2016) (133)
- Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. (2009) (128)
- Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps* (2012) (128)
- Role of Annexin A2 in the Production of Infectious Hepatitis C Virus Particles (2010) (127)
- Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany (2020) (126)
- Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication (2012) (125)
- An orthogonal proteomic survey uncovers novel Zika virus host factors (2018) (124)
- Three-Dimensional Architecture of Tick-Borne Encephalitis Virus Replication Sites and Trafficking of the Replicated RNA (2013) (124)
- The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response (2010) (122)
- The Lipid Kinase Phosphatidylinositol-4 Kinase III Alpha Regulates the Phosphorylation Status of Hepatitis C Virus NS5A (2013) (121)
- MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles (2012) (118)
- Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A (2009) (118)
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
- Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I)* (2011) (117)
- The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment (2002) (117)
- Dengue Virus- and Hepatitis C Virus-Induced Replication and Assembly Compartments: the Enemy Inside—Caught in the Web (2014) (117)
- Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase (1995) (115)
- Hepatitis C virus replication cycle. (2010) (115)
- Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. (2013) (115)
- A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein (2012) (114)
- Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses (2017) (112)
- Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras (2007) (112)
- Domain 3 of NS5A Protein from the Hepatitis C Virus Has Intrinsic α-Helical Propensity and Is a Substrate of Cyclophilin A* (2011) (110)
- Relation between viral fitness and immune escape within the hepatitis C virus protease (2005) (110)
- Mouse hepatic cells support assembly of infectious hepatitis C virus particles. (2011) (110)
- Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. (2007) (110)
- Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. (2011) (110)
- Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy (2007) (110)
- Efficient hepatitis C virus cell culture system: what a difference the host cell makes. (2005) (110)
- A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. (2012) (109)
- HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. (2018) (108)
- Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus (2015) (108)
- Efficient Rescue of Hepatitis C Virus RNA Replication by trans-Complementation with Nonstructural Protein 5A (2005) (106)
- Processing pathways of the hepatitis C virus proteins. (1996) (106)
- Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. (2001) (105)
- Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication (2008) (105)
- Selective Stimulation of Hepatitis C Virus and Pestivirus NS5B RNA Polymerase Activity by GTP* (1999) (102)
- Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. (2008) (100)
- Apolipoprotein E Likely Contributes to a Maturation Step of Infectious Hepatitis C Virus Particles and Interacts with Viral Envelope Glycoproteins (2014) (100)
- SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB (2020) (99)
- A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach (2010) (97)
- Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. (2009) (96)
- Interferon type I gene expression in chronic hepatitis C (2004) (95)
- Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells (2012) (95)
- Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology. (2017) (94)
- The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging (1989) (94)
- Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses (2017) (94)
- Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line (2005) (94)
- On the history of hepatitis C virus cell culture systems. (2014) (92)
- The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice. (2006) (90)
- Replication of the hepatitis C virus in cell culture. (2003) (90)
- Exploitation of cellular pathways by Dengue virus. (2011) (90)
- Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents (2016) (89)
- Molecular aspects of Dengue virus replication. (2008) (88)
- Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62 (2015) (88)
- New insights into structure and replication of the hepatitis C virus and clinical implications. (2010) (86)
- Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. (2006) (86)
- Novel Dengue Virus NS2B/NS3 Protease Inhibitors (2014) (86)
- The Interactomes of Influenza Virus NS1 and NS2 Proteins Identify New Host Factors and Provide Insights for ADAR1 Playing a Supportive Role in Virus Replication (2013) (84)
- Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus (2010) (84)
- Interferon-stimulated genes and their role in controlling hepatitis C virus. (2013) (81)
- Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha. (2003) (81)
- Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology. (2014) (80)
- Clearance of persistent hepatitis C virus infection using a claudin-1-targeting monoclonal antibody (2015) (79)
- Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies. (2012) (78)
- Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation (2009) (78)
- Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation. (2014) (78)
- Nuclear Localization of Dengue Virus Nonstructural Protein 5 Does Not Strictly Correlate with Efficient Viral RNA Replication and Inhibition of Type I Interferon Signaling (2013) (78)
- Chronic viral hepatitis and its association with liver cancer (2017) (76)
- Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes. (2018) (76)
- Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T‐cell protein tyrosine phosphatase (2009) (75)
- Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films (2008) (75)
- A splice hepadnavirus RNA that is essential for virus replication. (1996) (75)
- Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis (2011) (74)
- Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor (2014) (74)
- Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue. (2015) (74)
- New targets for antiviral therapy of chronic hepatitis C (2012) (73)
- Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication* (2005) (73)
- Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. (1991) (73)
- Perilipin discerns chronic from acute hepatocellular steatosis. (2014) (73)
- NS5A Domain 1 and Polyprotein Cleavage Kinetics Are Critical for Induction of Double-Membrane Vesicles Associated with Hepatitis C Virus Replication (2015) (73)
- In vitro studies on the activation of the hepatitis C virus NS3 proteinase by the NS4A cofactor. (1996) (72)
- The hepatitis C virus replicon system: from basic research to clinical application. (2005) (70)
- Subcellular Localization and Membrane Topology of the Dengue Virus Type 2 Non-structural Protein 4 B * □ (2006) (70)
- Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation (2015) (69)
- Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle (2013) (69)
- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (69)
- A Comprehensive Structure-Function Comparison of Hepatitis C Virus Strain JFH1 and J6 Polymerases Reveals a Key Residue Stimulating Replication in Cell Culture across Genotypes (2011) (68)
- Analysis of CD8+ T cell-mediated inhibition of hepatitis C virus replication using a novel immunological model (2009) (67)
- Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. (2008) (67)
- Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies. (2016) (67)
- Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection (2020) (67)
- Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor. (2016) (65)
- Hepatitis C Virus: From Molecular Virology to Antiviral Therapy (2013) (63)
- Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment. (2019) (63)
- Correlative light and electron microscopy methods for the study of virus–cell interactions (2016) (62)
- The duck hepatitis B virus P-gene codes for protein strongly associated with the 5'-end of the viral DNA minus strand. (1988) (62)
- Role of RNA Structures in Genome Terminal Sequences of the Hepatitis C Virus for Replication and Assembly (2009) (61)
- Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. (2001) (61)
- Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. (2003) (61)
- Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication (2021) (60)
- Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors. (2015) (60)
- Candidate targets for hepatitis C virus-specific antiviral therapy. (1997) (60)
- E2 of Hepatitis C Virus Inhibits Apoptosis1 (2005) (59)
- Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line (2009) (59)
- Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine (2006) (59)
- High-throughput screening using dengue virus reporter genomes. (2013) (58)
- Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes. (2018) (58)
- A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. (2009) (57)
- Hepatitis C Virus Replication Depends on Endosomal Cholesterol Homeostasis (2017) (57)
- Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines (2013) (57)
- A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021) (56)
- Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase* (2002) (56)
- Membrane alterations induced by nonstructural proteins of human norovirus (2017) (55)
- Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. (2006) (55)
- Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development. (2019) (55)
- High plasma level of nucleocapsid‐free envelope glycoprotein‐positive lipoproteins in hepatitis C patients (2012) (54)
- Identification of HNRNPK as Regulator of Hepatitis C Virus Particle Production (2015) (52)
- A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle (2019) (51)
- Targets for Antiviral Therapy of Hepatitis C (2014) (51)
- Conserved RNA secondary structures and long-range interactions in hepatitis C viruses (2015) (51)
- Low Oxygen Tension Enhances Hepatitis C Virus Replication (2012) (50)
- Single‐cell‐based image analysis of high‐throughput cell array screens for quantification of viral infection (2009) (50)
- HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells. (2006) (50)
- A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication (2015) (49)
- Aminoterminal Amphipathic α-Helix AH1 of Hepatitis C Virus Nonstructural Protein 4B Possesses a Dual Role in RNA Replication and Virus Production (2014) (49)
- Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2016) (48)
- Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A. (2015) (48)
- Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells (2020) (47)
- Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B (2013) (47)
- DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture (2015) (46)
- ER-shaping Atlastin proteins act as central hubs to promote flavivirus replication and virion assembly (2019) (46)
- Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity. (2017) (46)
- Detection of hepatitis C virus in paraffin‐embedded liver biopsies of patients negative for viral RNA in serum (1999) (46)
- A Slow Maturation Process Renders Hepatitis B Virus Infectious. (2016) (45)
- Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 (2020) (45)
- Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors (2008) (45)
- Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites. (1992) (45)
- Viral Infection at High Magnification: 3D Electron Microscopy Methods to Analyze the Architecture of Infected Cells (2015) (44)
- Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. (2013) (42)
- Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networks (2009) (42)
- Live Cell Analysis and Mathematical Modeling Identify Determinants of Attenuation of Dengue Virus 2’-O-Methylation Mutant (2015) (42)
- Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. (1999) (42)
- Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. (2012) (42)
- Immune protection against reinfection with nonprimate hepacivirus (2017) (40)
- Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions (2020) (39)
- Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication (2017) (38)
- An in vitro assay for hepatitis C virus NS3 serine proteinase. (1995) (38)
- Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A (2016) (37)
- Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development (2016) (37)
- Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys (2015) (36)
- Corrigendum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2005) (35)
- Semen inhibits Zika virus infection of cells and tissues from the anogenital region (2018) (35)
- Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin (2015) (35)
- C‐Src is required for complex formation between the hepatitis C virus–encoded proteins NS5A and NS5B: A prerequisite for replication (2011) (34)
- Synthesis, Biological Evaluation, and Molecular Docking of Combretastatin and Colchicine Derivatives and their hCE1‐Activated Prodrugs as Antiviral Agents (2019) (34)
- Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation (2021) (34)
- Tissue culture and animal models for hepatitis C virus. (2003) (33)
- Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly. (2009) (31)
- A Reverse Genetics System for Zika Virus Based on a Simple Molecular Cloning Strategy (2018) (31)
- Reovirus intermediate subviral particles constitute a strategy to infect intestinal epithelial cells by exploiting TGF‐β dependent pro‐survival signaling (2016) (30)
- Phosphorylation-Dependent Feedback Inhibition of RIG-I by DAPK1 Identified by Kinome-wide siRNA Screening. (2017) (30)
- Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes. (2019) (30)
- Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity. (2015) (28)
- Promotion of Hepatocellular Carcinoma by Hepatitis C Virus (2012) (28)
- Normalizing for individual cell population context in the analysis of high-content cellular screens (2011) (27)
- The quest for host targets to combat dengue virus infections. (2016) (27)
- TCR-Redirected Human T Cells Inhibit Hepatitis C Virus Replication: Hepatotoxic Potential Is Linked to Antigen Specificity and Functional Avidity (2012) (27)
- Novel non‐heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro (2018) (26)
- Optimization of Substrate‐Analogue Furin Inhibitors (2017) (26)
- Experimental models to study the immunobiology of hepatitis C virus. (2011) (26)
- Genome packaging of reovirus is mediated by the scaffolding property of the microtubule network (2017) (25)
- Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation (2021) (25)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5 A (2004) (25)
- Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients (2022) (25)
- Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2 (2021) (25)
- RACK1 mediates rewiring of intracellular networks induced by hepatitis C virus infection (2019) (25)
- A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication* (2015) (25)
- Structural Studies of Self-Assembled Subviral Particles: Combining Cell-Free Expression with 110 kHz MAS NMR Spectroscopy. (2018) (25)
- E2 of Hepatitis C Virus Inhibits Apoptosis (2005) (24)
- Scavenger Receptor BI Is a Key Host Factor for Hepatitis C Virus Infection Required for an Entry Step Closely Linked to CD 81 (2009) (24)
- Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (24)
- C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle. (2020) (22)
- Wheat germ cell-free expression: Two detergents with a low critical micelle concentration allow for production of soluble HCV membrane proteins. (2015) (22)
- Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin A. (2017) (21)
- Male offspring born to mildly ZIKV-infected mice are at risk of developing neurocognitive disorders in adulthood (2018) (21)
- Determinants of substrate specificity in the NS3 serine proteinase of the hepatitis C virus. (1997) (21)
- Hepatitis C virus replicons: dinosaurs still in business? (2009) (21)
- The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production (2014) (20)
- Identification of Terfenadine as an Inhibitor of HumanCD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization (2008) (20)
- The Hepatitis B Virus Envelope Proteins: Molecular Gymnastics Throughout the Viral Life Cycle. (2020) (19)
- The hepatitis C virus replicon system and its application to molecular studies. (2001) (19)
- Membrane undulation induced by NS4A of Dengue virus: a molecular dynamics simulation study (2014) (19)
- Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. (2004) (19)
- Discovery of highly divergent lineages of plant-associated astro-like viruses sheds light on the emergence of potyviruses. (2019) (18)
- Microscopy‐based assay for semi‐quantitative detection of SARS‐CoV‐2 specific antibodies in human sera (2020) (18)
- Interferon‐induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20 (2021) (18)
- A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner (2017) (18)
- Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2 (2021) (17)
- Adaptation of the hepatitis C virus to cell culture. (2009) (17)
- Lipid droplet quantification based on iterative image processing[S] (2019) (17)
- A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection (2020) (17)
- Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site. (2013) (17)
- Detecting host factors involved in virus infection by observing the clustering of infected cells in siRNA screening images (2010) (17)
- Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes (2007) (17)
- Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin (2014) (16)
- The Role of Tissue Oxygen Tension in Dengue Virus Replication (2018) (16)
- Functional expression, purification, characterization, and membrane reconstitution of non-structural protein 2 from hepatitis C virus. (2015) (16)
- Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein (2021) (16)
- A Non-Replicative Role of the 3′ Terminal Sequence of the Dengue Virus Genome in Membranous Replication Organelle Formation (2020) (16)
- Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination (2021) (16)
- Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. (2017) (15)
- SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models (2022) (15)
- An alternative membrane topology permits lipid droplet localization of peroxisomal fatty acyl-CoA reductase 1 (2018) (15)
- Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis (2022) (15)
- A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2 (2020) (15)
- Novel indole–flutimide heterocycles with activity against influenza PA endonuclease and hepatitis C virus (2016) (15)
- Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3 (2012) (14)
- High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay. (2013) (14)
- A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication (2015) (14)
- A Recurrent Neural Network for Particle Tracking in Microscopy Images Using Future Information, Track Hypotheses, and Multiple Detections (2020) (14)
- Hepatitis C Virus Replication. (2019) (14)
- Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family (2016) (13)
- Unexpected host range of hepatitis C virus replicons (2004) (13)
- Glycine Zipper Motifs in Hepatitis C Virus Nonstructural Protein 4B Are Required for the Establishment of Viral Replication Organelles (2017) (13)
- Hepatitis C virus exploits cyclophilin A to evade PKR (2020) (13)
- Proton‐Detected Solid‐State NMR of the Cell‐Free Synthesized α‐Helical Transmembrane Protein NS4B from Hepatitis C Virus (2019) (13)
- Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. (2014) (12)
- Structural and Functional Properties of the Hepatitis C Virus p 7 Viroporin (2015) (12)
- The cyclophilin inhibitor Debio-025 is a potent inhibitor of hepatitis C virus replication in vitro with a unique resistance profile (2006) (12)
- Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo. (2011) (12)
- Deep Particle Tracker: Automatic Tracking of Particles in Fluorescence Microscopy Images Using Deep Learning (2018) (12)
- Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients (2022) (12)
- A novel function for a micro RNA: Negative regulators can do positive for the hepatitis C virus (2006) (12)
- Erratum for Roth et al., “Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses” (2017) (12)
- In vitro models for hepatitis C. (2001) (12)
- Modulation of Hepatitis C Virus NS 5 A Hyperphosphorylation by Nonstructural Proteins NS 3 , NS 4 A , and NS 4 B JAN (1999) (11)
- Heterologous Src Homology 4 Domains Support Membrane Anchoring and Biological Activity of HIV-1 Nef* (2014) (11)
- The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters (2022) (11)
- Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation (2020) (11)
- Correction: Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics (2009) (11)
- HCV modifies EGF signalling and upregulates production of CXCR2 ligands: Role in inflammation and antiviral immune response. (2018) (11)
- Reciprocal Effects of Fibroblast Growth Factor Receptor Signaling on Dengue Virus Replication and Virion Production. (2019) (11)
- Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread. (2022) (11)
- The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection (2022) (10)
- Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers (2022) (10)
- Detnet: Deep Neural Network For Particle Detection In Fluorescence Microscopy Images (2019) (10)
- Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN). (2013) (9)
- Expression of the Novel Hepatitis C Virus Core+1/ARF Protein in the Context of JFH1-Based Replicons (2015) (9)
- Editorial: An expanded view of viruses (2017) (9)
- Correlative Light Electron Microscopy (CLEM) for Tracking and Imaging Viral Protein Associated Structures in Cryo-immobilized Cells (2018) (9)
- Using soft X-ray tomography for rapid whole-cell quantitative imaging of SARS-CoV-2-infected cells (2021) (9)
- Deciphering the Origin and Evolution of Hepatitis B Viruses (2018) (8)
- mRNAs biotinylated within the 5′ cap and protected against decapping: new tools to capture RNA–protein complexes (2018) (8)
- Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication (2021) (8)
- Alternative approaches for effecient inhibition of hepatitis C virus RNA replication (2004) (8)
- Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication (2019) (8)
- Dimer Organization of Membrane‐Associated NS5A of Hepatitis C Virus as Determined by Highly Sensitive 1H‐Detected Solid‐State NMR (2020) (8)
- Persistent intracellular pathogens. (2012) (8)
- TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus (2016) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- From Multiplex Serology to Serolomics—A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome (2020) (7)
- P0676 : Clearance of persistent hepatitis c virus infection using a monoclonal antibody specific for tight junction protein claudin-1 (2015) (7)
- The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin (2021) (7)
- SARS‐CoV‐2 infection remodels the host protein thermal stability landscape (2021) (7)
- TLR3 Activation by Zika Virus Stimulates Inflammatory Cytokine Production Which Dampens the Antiviral Response Induced by RIG-I-Like Receptors (2021) (7)
- Erratum: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (Nature Medicine (2005) 11 (791-796)) (2005) (7)
- Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6) (2015) (7)
- Hyperparameter optimization for image analysis: application to prostate tissue images and live cell data of virus-infected cells (2019) (7)
- Broad neutralization of hepatitis C virus‐resistant variants by Civacir hepatitis C immunoglobulin (2016) (7)
- Towards curative therapy of chronic viral hepatitis (2019) (7)
- Two-filter probabilistic data association for tracking of virus particles in fluorescence microscopy images (2018) (7)
- Hepatitis C virus RNA replication is resistant to tumour necrosis factor-a (2003) (7)
- Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk. (2019) (7)
- The predominant species of nonstructural protein 4B in hepatitis C virus-replicating cells is not palmitoylated (2015) (6)
- Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Post-Binding Steps and Membrane Fusion (2008) (6)
- Compact Cell Imaging Device (CoCID) provides insights into the cellular origins of viral infections (2021) (6)
- Replication-Independent Generation and Morphological Analysis of Flavivirus Replication Organelles (2020) (6)
- Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial (2022) (6)
- Hepatitis C Virus Replication in Cell Culture (2004) (6)
- Hepatitis C virus. (2004) (6)
- Novel nucleoside analogues targeting HCV replication through an NS5A‐dependent inhibition mechanism (2017) (6)
- IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis (2009) (6)
- A protocol for full-rotation soft X-ray tomography of single cells (2022) (6)
- Colocalization analysis and particle tracking in multi-channel fluorescence microscopy images (2017) (6)
- Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients (2021) (6)
- Mechanisms governing hepadnaviral nucleocapsid assembly. (1993) (6)
- The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein (2021) (5)
- HCV: The Journey from Discovery to a Cure: Volume I (2019) (5)
- Deep Learning Particle Detection for Probabilistic Tracking in Fluorescence Microscopy Images (2020) (5)
- Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid (2022) (5)
- The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment (2021) (5)
- Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds (2019) (5)
- Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy (2016) (5)
- A sensor at the lipid‐protein interface: Lipid peroxidation controls hepatitis C virus replication (2015) (5)
- Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response (2013) (5)
- Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses (2020) (5)
- Structures and distributions of SARS-CoV-2 spike proteins on intact virions (2020) (5)
- Faculty Opinions recommendation of Genome-scale CRISPR-Cas9 knockout screening in human cells. (2014) (4)
- Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients (2021) (4)
- Combined analysis of metabolomes, proteomes, and transcriptomes of HCV-infected cells and liver to identify pathways associated with disease development (2019) (4)
- Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication (2016) (4)
- Waning Immunity 14 Months After SARS-Cov-2 Infection. (2022) (4)
- Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model (2017) (4)
- Dimer Organization of Membrane‐Associated NS5A of Hepatitis C Virus as Determined by Highly Sensitive 1 H‐Detected Solid‐State NMR (2021) (4)
- Prodrug Activation by a Viral Protease: Evaluating Combretastatin Peptide Hybrids To Selectively Target Infected Cells. (2019) (4)
- SARS-CoV-2 infection remodels the host protein thermal stability landscape (2020) (4)
- Hepatitis C Virus-From Discovery to Cure: The 2016 Lasker-DeBakey Clinical Medical Research Award. (2016) (3)
- Deep probabilistic tracking of particles in fluorescence microscopy images (2021) (3)
- [Molecular mechanisms of hepatitis C virus (HCV) replication - implications for the development of antiviral drugs]. (2011) (3)
- Integrative Imaging Reveals SARS-CoV-2 Induced Reshaping of Subcellular Morphologies (2020) (3)
- The novel Lambda-interferons IL-28A and IL-29 inhibit HCV replication in vitro and hepatic IL-28 mRNA expression is increased in HCV and CMV infection in vivo (2006) (3)
- Antiviral strategies. Preface. (2009) (3)
- Hepatitis viruses in the XXI century. (2007) (3)
- Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy (2022) (3)
- [Pathogenesis and pathomorphology of chronic viral hepatitis]. (2005) (3)
- Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA‐Virus Inhibitors (2022) (3)
- The Heme oxygenase 1 product Biliverdin interferes with HCV replication by increasing anti-viral interferon response (2010) (3)
- Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS 5 A protein (2003) (3)
- Title : Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4 B (3)
- Bringing the Hepatitis C Virus to Life (2016) (3)
- The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication (2021) (3)
- COVID-19 severity and complications associated with low diversity, dysbiosis and predictive metagenome features of the oropharyngeal microbiome. (2021) (3)
- Temporal control of the integrated stress response by a stochastic molecular switch (2022) (3)
- Characterisation of interferon alfa-2a and pegylated interferon alfa-2A in combination with ribavirin, mycophenolic acid or VX-497 as inhibitors of HCV replicon replication (2001) (3)
- A snapshot of protein trafficking in SARS‐CoV‐2 infection (2022) (2)
- Determinants in Nonstructural Protein 4A of Dengue Virus Required for RNA Replication and Replication Organelle Biogenesis (2021) (2)
- Corrigendum: Conserved RNA secondary structures and long-range interactions in hepatitis C viruses. (2016) (2)
- Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication. (2022) (2)
- [Hepatitis C: From Individual Cure to Worldwide Elimination?] (2019) (2)
- Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg , Germany for the degree of Doctor of Natural Sciences (2007) (2)
- Deep mining of the Sequence Read Archive reveals bipartite coronavirus genomes and inter-family Spike glycoprotein recombination (2021) (2)
- Stochastic dynamics of Type-I interferon responses (2022) (2)
- Use of the HCV subgenomic replicon for the selection and characterization of variants with reduced susceptibility to interferon alpha-2A (2001) (2)
- 129 MODULATION OF PHOSPHORYLATION OF HEPATITIS C VIRUS NONSTRUCTURAL PROTEIN 5A BY THE LIPID KINASE PI4KIIIα (2012) (2)
- 665 CULTURE OF HEPATITIS C VIRUS (HCV) IN PRIMARY HUMAN ADULT HEPATOCYTES: A PHYSIOLOGICAL MODEL FOR THE PRODUCTION OF AUTHENTIC INFECTIOUS PARTICLES (2010) (2)
- Dengue virus is sensitive to inhibition prior to productive replication. (2021) (2)
- Hepatitis C virus's next top models? (2016) (2)
- O.171 HDL inhibits HCV neutralisation by CD81-NOB antibodies by stimulating cell entry through activation of the scavenger receptor BI (2006) (2)
- Interferon-gamma induced clearance of an HCV subgenomic replicon: a role for nitric oxide? (2001) (2)
- Serum versus intrahepatic HCV RNA and liver histology (2002) (2)
- Discovery and prioritization of human cellular factors required for HCV infection (2010) (1)
- An expanded view of viruses (2016) (1)
- Inhibition of hepatitis C virus by nucleic acid-based antiviral approaches (2006) (1)
- Structure and function of the membrane domain of hepatitis C virus nonstructural protein 5A (2004) (1)
- Biosynthesis and Enzymatic Functions of the Hepadnaviral Reverse Transcriptase (2018) (1)
- Hepatitis C virus replicons volume 3 and 4. (2013) (1)
- A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo (2022) (1)
- Short Communication Hepatitis C virus RNA replication is resistant to tumour necrosis factor-a (2003) (1)
- HBV bypasses the innate immune system and does not protect HCV against the antiviral effect of IFN (2018) (1)
- 607 NEUTRALIZING HOST RESPONSES IN HEPATITIS C VIRUS INFECTION TARGET VIRAL ENTRY AT POST-BINDING STEPS AND MEMBRANE FUSION (2008) (1)
- In Vitro Replication Models (2013) (1)
- 41 RECRUITMENT AND ACTIVATION OF A LIPID KINASE BY NS5A OF THE HEPATITIS C VIRUS IS ESSENTIAL FOR THE INTEGRITY OF THE MEMBRANOUS REPLICATION COMPARTMENT (2011) (1)
- A Novel Cis-Acting RNA Structural Element Embedded in the Core Coding Region of the Hepatitis C Virus Genome Directs Internal Translation Initiation of the Overlapping Core+1 ORF (2020) (1)
- Induction of heme oxygenase 1 by HMG-CoA-Reductase inhibitors interferes with HCV replication (2012) (1)
- Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose (2023) (1)
- 1150 HEPATITIS C VIRUS LIVER TRANSPLANTATION ESCAPE VARIANT IS CHARACTERIZED BY BOTH ENHANCED TRIGLYCERIDE-RICH LIPOPROTEIN ASSOCIATION AND SENSITIVITY TO apoE ANTIBODIES (2013) (1)
- European Training Network on (+)RNA Virus Replication and Antiviral Drug Development (2011) (1)
- P096: Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication via blockage of membranous web formation (2015) (1)
- ID: 105: Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus (2015) (1)
- Role of autophagy in hepatitis C virus replication (2019) (1)
- The Hepatitis C Virus Replicon System and Its Role in Drug Development (2019) (1)
- Kinetic, mechanistic and chemodynamic characterisation of non-nucleoside hepatitis C virus NS5B polymerase inhibitors using SPR biosensor technology (2009) (1)
- [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E]. (2017) (1)
- Direct and synergistic inhibition of hepatitis C virus replication by cyclosporin a and myocophenolic acid. (2006) (1)
- Faculty Opinions recommendation of Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. (2016) (1)
- Inhibition of WNT signalling interferes with HCV replication (2013) (1)
- P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy (2015) (1)
- Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates (2023) (1)
- Genotypic resistance testing of HCV – is there a clinical need? (2016) (1)
- Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier (2021) (1)
- Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection (2023) (1)
- Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2017) (1)
- Automated Analysis of siRNA Screens of Virus Infected Cells Based on Immunofluorescence Microscopy (2008) (1)
- Down regulation of osteopontin interferes with HCV replication by inhibition of WNT signalling in vitro (2013) (1)
- Data fusion and smoothing for probabilistic tracking of viral structures in fluorescence microscopy images (2021) (1)
- Contents, Vol. 40, 1997 (1997) (0)
- Nanoparticular Inhibitors of Flavivirus Proteases from Zika, West Nile and Dengue Virus Are Cell-Permeable Antivirals. (2021) (0)
- Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis (2022) (0)
- Serological response and disease-specific neutralizing antibodies in kidney transplant recipients with SARS-CoV-2 infection – a case series (2020) (0)
- 45 IDENTIFICATION OF EFFECTORS OF THE INTERFERON-INDUCED ANTIVIRAL RESPONSE AGAINST HEPATITIS C VIRUS (2011) (0)
- P119: Hepatitis C virus inhibits IL‐1 β‐induced IкBζ expression and thereby antagonizes mechanisms which may affect cell proliferation (2015) (0)
- Infection of primary human hepatocytes with recombinant hepatitis C virus (2008) (0)
- Hepatitis C virus inhibits IL-1β-induced IκBζ expression in a Calpain- and MK2-dependent manner resulting in LCN2 suppression (2015) (0)
- Author response: Hepatitis C virus exploits cyclophilin A to evade PKR (2020) (0)
- Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021) (0)
- Cancer Research at Dkfz 2016 Inflammation, Infection and Cancer (2017) (0)
- Cell culture systems for the hepatitis C virus and their application for development of specifically targeted antiviral therapy for hepatitis C (Stat-C) (2010) (0)
- N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle (2023) (0)
- Cancer Research at Dkfz 2016 Inflammation, Infection and Cancer (2017) (0)
- P131 HEPATITIS C VIRUS SUPPRESSES ErbB3 EXPRESSION VIA ENHANCED PRODUCTION OF ITS LIGAND NEUREGULIN 1 (2014) (0)
- Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors (2019) (0)
- Chronic hepatitis C: Portrait of a silent epidemic and the etiologic agent (2008) (0)
- Automated Single Cell Based Analysis of siRNA Screens of HumanCells Infected by Hepatitis C and Dengue Viruses Based onImmunofluorescence Microscopy Images (2008) (0)
- Biogenesis, structure and dynamic of the hepatitis C virus replication complex (2007) (0)
- P116: The Impact of obesity‐related hormones on the HCV life‐cycle (2015) (0)
- Enzymatic activity of Phosphatidyl-inositol-4 kinase III alpha (PI4KIIIα) is critically involved in HCV replication and regulated by HCV NS5A (2011) (0)
- Lipid droplets and associated proteins in viral hepatitis (2019) (0)
- P146: Early reduction of serum fibrosis marker and tumor marker in patients treated with daclatasvir and asunaprevir (2015) (0)
- Genetically encoded FRET sensor to detect double- stranded RNA during viral infection (2019) (0)
- Structural conservation of HBV-like capsid proteins over hundreds of millions of years despite the shift from non-enveloped to enveloped life-style (2023) (0)
- Hepatitis B virus targets lipid transport pathways to infect hepatocytes. (2023) (0)
- Male offspring born to mildly ZIKV-infected mice are at risk of developing neurocognitive disorders in adulthood (2018) (0)
- Can we predict antibody responses in SARS-CoV-2? A cohort analysis. (2021) (0)
- Acknowledgment of Reviewers 2013 (2013) (0)
- O.138 Modulation of endoplasmic reticulum (ER) calcium signalling affects hepatitis C virus (HCV) protein expression and replication (2006) (0)
- Hepatitis C virus RNAs replicating in cell culture (2000) (0)
- The interaction of the Hepatitis C Virus with intra-cellular signaling converts EGF into a potent inducer of the production of CXCR2-ligands by the infected host cell (2015) (0)
- Chronic hepatitis C: portrait of a silent epidemic. (2008) (0)
- A Novel System to Study Dengue Virus Replication Organelle Formation Independent from Viral RNA Replication (2020) (0)
- PHOSPHORYLATION-DEPENDENT FEEDBACK-INHIBITION OF RIG-I BY THE DEATH ASSOCIATED PROTEIN KINASE 1 IDENTIFIED BY KINOME-WIDE SIRNA SCREENING (2016) (0)
- 847 COFFEE INTERFERES WITH HCV REPLICATION IN VITRO BY INHIBITION OF WNT SIGNALING (2012) (0)
- Solution structure of NS2 [27-59] (2011) (0)
- Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (0)
- Sequences in the 5 (cid:2) Nontranslated Region of Hepatitis C Virus Required for RNA Replication (2001) (0)
- Solution structure of NS2 [60-99] (2011) (0)
- 1189 NEXT GENERATION SEQUENCING AND IN VITRO CHARACTERIZATION REVEAL POPULATION BOTTLENECKS AND FIXATION OF SELECTIVELY NEUTRAL MUTATIONS OCCURS POST-BI 201335 THERAPY (2013) (0)
- Twenty-Fourth International Conference on Antiviral Research - Front Pages (2011) (0)
- Hepatitis C Virus EGF-dependently induces the release of CXCR2 ligands and enhances their EGF-inducible release via distinct pathways (2018) (0)
- P148: Early virological response is a predictor of treatment response in sofosbuvir‐based combination therapy of chronic hepatitis c in a multi‐center “real‐life” cohort (2015) (0)
- Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (0)
- 18 BILE ACIDS ENHANCE GENOTYPE 1 HEPATITIS C VIRUS REPLICATION (2008) (0)
- Editorial Board (2016) (0)
- Automated analysis of siRNA screens of cells infected by hepatitis C and dengue viruses based on immunofluorescence microscopy images (2008) (0)
- Identification of host cell factors involved in hepatitis C virus replication (2019) (0)
- O.137 HDL inhibits neutralisation by HCV antibodies via a ternary interaction with the scavenger receptor BI (2006) (0)
- Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies (2022) (0)
- Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen (2022) (0)
- Type I and type II interferon responses in two human liver cell lines ( Huh-7 and HuH 6 ) (2016) (0)
- Faculty Opinions recommendation of An essential receptor for adeno-associated virus infection. (2016) (0)
- O52 APOLIPOPROTEIN E MEDIATES HCV ESCAPE FROM HOST NEUTRALIZING ANTIBODIES (2014) (0)
- AUTOMATIC SINGLE-CELL-BASED ANALYSIS OF siRNA SCREENS BASED ON IMMUNOFLUORESCENCE MICROSCOPY (2009) (0)
- 809 HEPATITIS C VIRUS PERSISTENCE IN QUIESCENT HEPATIC CELLS UNDER CONDITIONS OF AN INTERFERON-INDUCED ANTIVIRAL RESPONSE (2012) (0)
- P0473 : The hepatitis C virus modifies CXC chemokine expression induced by inflammatory cytokines and facilitates their production in response to epidermal growth factor (2015) (0)
- O.067 Hepatitis C virus: Virology, immunology, natural history, treatment (2006) (0)
- Hepatitis C Virus activates auto- and paracrine circuits to modify surface expression of growth factor receptors of the Erb family (2015) (0)
- Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras (cid:1) (2007) (0)
- 318 THE HEPATITIS C VIRUS ENHANCES ACTIVATION OF THE EGF-RECEPTOR AND AKT-ACTIVITY BY NS3/4A-MEDIATED CLEAVAGE OF THE T-CELL PROTEIN TYROSINE PHOSPHATASE (2009) (0)
- Influence of HCV on CREB gene expression and functional relevance (2015) (0)
- P130 HEPATITIS C VIRUS PREVENTS IL-1β-INDUCED EXPRESSION OF LIPOCALIN2 VIA SUPPRESSION OF IκBζ (2014) (0)
- Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction (2021) (0)
- 792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
- The Twentieth International Conference on Antiviral Research (2007) (0)
- Endosomal egress and intercellular transmission of hepatic ApoE-containing lipoproteins and its exploitation by the hepatitis C virus (2022) (0)
- Virus Replication Low Oxygen Tension Enhances Hepatitis C (2014) (0)
- Simultaneous targeting of HCV replication and viral entry by a single gene therapy vector containing multiple RNA interference cassettes: prevention of mutational escape (2006) (0)
- Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal (2020) (0)
- PB2270: CLEARANCE OF PERSISTENT SARS-COV2 INFECTION WITH ANTIBODY CONTAINING PLASMA IN LEUKEMIA AND LYMPHOMA PATIENTS (2022) (0)
- , Simone Sites and Trafficking of the Replicated RNA Tick-Borne Encephalitis Virus Replication Three-Dimensional Architecture of (2013) (0)
- P118: The Hepatitis C Virus (HCV) facilitates CXCR2 ligand expression in response to the Epidermal Growth Factor (EGF) and is able to induce the EGF production by an autocrine circuit in its host cell (2015) (0)
- Title Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids , viral vectors and cell lines (2018) (0)
- Vitamin D3, 25(OH) vitamin D3 and the synthetic vitamin D3 analogue Seocalcitol reduce HCV replication (2013) (0)
- 417 Subgenomic hepatitis C replicon deriving from a clinical isolate with virologic non-response to IFN-based therapy and IFN resistance in vitro (2006) (0)
- VIRAL FITNESS COST AND T CELL CROSS-RECOGNITION LIMIT VIRAL ESCAPE WITHIN A PROTECTIVE HLA-B27 RESTRICTED HEPATITIS C VIRUS SPECIFIC CD8+T CELL EPITOPE (2008) (0)
- Hepatitis C: A mouse at the end of the tunnel (2013) (0)
- REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014) (0)
- Activation of the interferon response by HCV is mediated by MDA5 and potentiated by LGP2 (2019) (0)
- 762 STUDIES OF HEPATITIS C VIRUS PERSISTENCE UNDER INTERFERON TREATMENT IN A NOVEL CELL CULTURE MODEL (2011) (0)
- 472 Comparative Analysis of the Antiviral Properties and the Transcriptome of the Lambda-Interferons IL-28A and IL-29: Significant Differences in Gene Repression (2010) (0)
- Hepatitis C Virus mediates induction of CXC chemokine expression in response to the inflammatory cytokines TNFα and IL-1β (2019) (0)
- Ultrastructural Characteri zation of Zika Virus Replication Factories Graphical Abstract Highlights (0)
- Whole-cell quantitative imaging of structural changes induced by SARS-CoV-2 using soft X-ray tomography (2022) (0)
- This information is current as Functional Avidity Potential Is Linked to Antigen Specificity and Hepatitis C Virus Replication : Hepatotoxic TCR-Redirected Human T Cells Inhibit (2012) (0)
- P117: Hepatitis C Virus mediates NRG1‐dependent down‐regulation of ErbB3, thereby modifies ErbB receptor family composition at the cell surface (2015) (0)
- Editorial Board (2016) (0)
- SARS-CoV-2 nsp3-4 suffice to form a pore shaping replication organelles (2022) (0)
- Phosphorylation-Depende nt Feedback Inhibition of RIGI by DAPK 1 Identified by Kinome-wide siRNA Screening Graphical (2017) (0)
- Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies (2023) (0)
- PS-032-Impact of antigen recognition on memory-like HCV-specific CD8+ T-cells (2019) (0)
- Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients (2022) (0)
- NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 100mM DPC) (2004) (0)
- Purification of HCV-remodeled and Control ER Membranes (2014) (0)
- Subject Index Vol. 40, 1997 (1997) (0)
- Going full circle: validation of P-body dispersion in hepatitis C virus-infected patients. (2015) (0)
- 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial (2022) (0)
- Cytokines and hepatitis C virus replication (2002) (0)
- Faculty Opinions recommendation of Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. (2015) (0)
- Faculty Opinions recommendation of The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells. (2011) (0)
- An orthogonal proteomic survey uncovers novel Zika virus host factors (2018) (0)
- Towards structural studies of self-assembled subviral particles: combining cell-free expression with 100 kHz MAS NMR. (2018) (0)
- Ex-vivo gene therapy of the liver: new approach to tackle hepatitis C infection and recurrence after liver transplantation. (2006) (0)
- Hepatitis C virus inhibits IL-1β-induced IκBζ expression in a Calpain-dependent manner resulting in LCN2 suppression (2019) (0)
- Contribution of the Cellular Lipid Kinase PI4KA to HCV-induced Liver Pathogenesis (2022) (0)
- Positive‐strand RNA viruses—a Keystone Symposia report (2023) (0)
- Modified genomic rna of the human hepatitis C virus with autonomous replication competence (2005) (0)
- Acknowledgment of Reviewers for 2011 (2012) (0)
- ID: 219: DAPK1: A novel regulator of RIG-I identified by Kinome-Wide siRNA screening (2015) (0)
- P147: A phenotypic NS3‐protease inhibitor resistance assay to characterize resistance‐associated mutations in patients (2015) (0)
- The Hepatitis C Virus RNA 3 (cid:2) -Untranslated Region Strongly Enhances Translation Directed by the Internal Ribosome Entry Site (cid:1) (2006) (0)
- Use of the HCV subgenomic replicon for the selection and characterisation of variants with reduced susceptibility to interferon alfa-2a (2001) (0)
- 1H, 15N and 13C backbone resonance assignments of domain 2 (D2) of the non-structural 5A protein (NS5A) from the JFH1 Hepatitis C virus (HCV) strain. (2009) (0)
- 785 INNATE SIGNALING BY HEPATITIS C VIRUS IS RIG-I AND MDA5 DEPENDENT AND MODULATED BY NS5A DOMAIN II (2012) (0)
- Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation (2022) (0)
- 767 C-SRC IS REQUIRED FOR VIRAL REPLICATION AS IT MEDIATES COMPLEX FORMATION BETWEEN THE HEPATITIS C VIRUS ENCODED PROTEINS NS5A AND NS5B (2011) (0)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A*□S (2004) (0)
- P129 HEPATITIS C VIRUS MEK1- AND TC-PTP-DEPENDENTLY CONVERTS EPIDERMAL GROWTH FACTOR (EGF) INTO A POTENT INDUCTOR OF CXCR2 LIGAND EXPRESSION (2014) (0)
- S1008 The Role of the Novel IL-10-Related Cytokines IL-22, IL-26, IL-28a/B, and IL-29 in Hepatitis C Virus Infection (2008) (0)
- Extracellular vesicles from Zika virus‐infected cells display viral E protein that binds ZIKV‐neutralizing antibodies to prevent infection enhancement (2023) (0)
- Perilipin-1 differentiates chronic from acute hepatocyte steatosis (2013) (0)
- Interleukin-26 enhances proinflammatory gene expression and its expression is increased in intestinal inflammation in vivo (2007) (0)
- PLOS Pathogens 2017 Reviewer and Editorial Board Thank You (2018) (0)
- Mechanisms Regulating Nucleocapsid Formation of the Hepatitis B Viruses (1993) (0)
- Deep Neural Network for Combined Particle Tracking and Colocalization Analysis in Two-Channel Microscopy Images (2022) (0)
- Integrative imaging reveals SARS-CoV-2 induced reshaping of subcellular morphologies. Cortese et al. (2020) (0)
- Mechanisms Controlling Hepadnaviral Nucleocapsid Assembly and Replication (1993) (0)
- Deep Learning For Particle Detection And Tracking In Fluorescence Microscopy Images (2021) (0)
- Differences in the antiviral properties of the novel IL-10 like cytokines IL-26, IL-28A/B, and IL-29 against hepatitis C virus infection (2008) (0)
- Hepatitis C Virus Replication Compartment Characterization of the Membranous Morphological and Biochemical (2014) (0)
- ThePGeneProduct ofHepatitis B Virus IsRequired as a Structural Component forGenomicRNA Encapsidation (1990) (0)
- Tracking of Particles in Fluorescence Microscopy Images Using a Spatial Distance Model for Brownian Motion (2020) (0)
- The Hepatitis C Virus (HCV) results in an increased attraction of human neutrophils to its host cell by a basal and EGF-induced CXCR2 ligand expression (2015) (0)
- Protection by HLA-B27 in HCV infection: role of virological and immunological factors (2008) (0)
- Evaluation of siRNA Screens of Cells Infected by Hepatitis Cand Dengue Viruses based on Immunofluorescence Microscopy (2008) (0)
- Semen inhibits Zika virus infection of cells and tissues from the anogenital region (2018) (0)
- GASL 2019 (2019) (0)
- Impact of stable CypA or CypB knock-down on RNA replication of genotype 2a and 1b replicons. (2009) (0)
- A monocytic detour to replicate patient‐derived hepatitis C virus in hepatoma cells and its use for phenotypic analyses (2015) (0)
- Advances in the study and treatment of liver diseases (2019) (0)
- The pivotal role of target cells in modulating efficacy of antiviral CD8 T cell immunity in the liver (2019) (0)
- HBV-HCV Coinfection: Insights from a Novel Model System (2008) (0)
This paper list is powered by the following services:
Other Resources About Ralf Bartenschlager
What Schools Are Affiliated With Ralf Bartenschlager?
Ralf Bartenschlager is affiliated with the following schools: